Medytox

Medytox, Inc. was founded in 2000 and is a research-based biopharmaceutical company in South Korea. Its main products include botulinum toxin (Botox), hyaluronic acid dermal fillers (HAfiller), and medical devices. As the fourth company globally to successfully develop and produce botulinum toxin, Medytox owns Neuronox, the leading botulinum toxin brand in the South Korean market. Since 2006, Neuronox has been approved for marketing in 27 countries worldwide.